Proteomic analysis of peritoneal fluid of patients treated by peritoneal dialysis: Effect of glucose concentration

Nephrology Dialysis Transplantation

Volumn 26, Issue 6, 2011, Pages 1990-1999

  Cuccurullo, Manuela ^a   Evangelista, Ciriana ^a   Vilasi, Annalisa ^a   Simeoni, Mariadelina ^a   Avella, Ferdinando ^c   Riccio, Eleonora ^d   Memoli, Bruno ^d   Malorni, Antonio ^b   Capasso, Giovambattista ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b CNR   (Italy)

^c Nola General Hospital   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

mass spectrometry; peritoneal dialysis; proteomics

Indexed keywords

ALPHA 1 ANTITRYPSIN; APOLIPOPROTEIN A4; FIBRINOGEN; FIBRINOGEN BETA CHAIN; GLUCOSE; PREALBUMIN; PROTEOME; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY FAILURE; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PERITONEAL DIALYSIS; PERITONEAL FLUID; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADULT; AGED; ASCITIC FLUID; BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GLUCOSE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PROGNOSIS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 79958099817     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq670     Document Type: Article

References (33)

1. Anderson NL, Anderson NG. The Human Plasma Proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002; 1: 845-867.
2. Anderson NL, Polanski M, Pieper R et al. The human plasma proteome: a nonredundant list developed by combination of four separate sources. Mol Cell Proteomics 2004; 3: 311-326.
3. Arthur JM, Thongboonkerd V, Scherzer JA et al. Differential expression of proteins in renal cortex and medulla: a proteomic approach. Kidney Int 2002; 62: 1314-1321.
4. Ashburner M, Ball C, Blake J et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000; 25: 25-29. (Pubitemid 30257031)
5. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Chem 1976; 72: 248-254.
6. Brewis IA, Topley N. Proteomics and peritoneal dialysis: early days but clear potential. Nephrol Dial Transplant 2010; 25: 1749-1753.
7. Carrell R, Travis J. α1-Antitrypsin and the serpins: variation and countervariation. Trends Biochem Sci 1985; 10: 20-24.
8. Carrell RW. alpha 1-Antitrypsin: molecular pathology, leukocytes, and tissue damage. J Clin Invest 1986; 78: 1427-1431. (Pubitemid 17219502)
9. Devuyst O, Nielsen S, Cosyns JP et al. Aquaporin-1 and endothelial nitric oxide synthase expression in capillary endothelia of human peritoneum. Am J Physiol 1998; 275: H234-H242.
10. Dinubile M. Plasma gelsolin: in search of its raison d'etre. Focus on "Modifications of cellular responses to lysophosphatidic acid and platelet-activating factor by plasma gelsolin". Am J Physiol Cell Physiol 2007; 292: 1240-1242.
11. Gillerot G, Devuyst O. Changes in the peritoneal membrane with peritoneal dialysis: molecular mechanisms. Clin Nephrol 2003; 60: 1-6. (Pubitemid 36889546)
12. Gillerot G, Goffin E, Catherine M et al. Genetic and clinical factors influence the baseline permeability of the peritoneal membrane. Kidney Int 2005; 67: 2477-2487. (Pubitemid 41623413)
13. Kaiser T, Hermann A, Kielstein JT et al. Capillary electrophoresis coupled to mass spectrometry to establish polypeptide pattern in dialysis. J Chromatogr A 1013; 2003: 157-171. (Pubitemid 37297583)
14. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
15. Lin WT, Tsai CC, Chen CY et al. Proteomic analysis of peritoneal dialysate fluid in patients with dialysis-related peritonitis. Ren Fail 2008; 30: 772-777.
16. Maere S, Heymans K, Kuiper M. BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 2005; 21: 3448-3449. (Pubitemid 41222459)
17. Margetts PJ, Churchill DN. Acquired ultrafiltration dysfunction in peritoneal dialysis patients. J Am Soc Nephrol 2002; 13: 2787-2794. (Pubitemid 35216050)
18. Mariano F, Tetta C, Montrucchio G et al. Role of alpha 1-proteinase inhibitor in restraining peritoneal inflammation in CAPD patients. Kidney Int 1992; 42: 735-742.
19. Miyata T, Devuyst O, Kurokawa K et al. Toward better dialysis compatibility: advances in the biochemistry and pathophysiology of the peritoneal membranes. Kidney Int 2002; 61: 375-386. (Pubitemid 34102577)
20. O'Farrell PH. High resolution two-dimensional electrophoresis of proteins. J Biol Chem 1975; 250: 4007-4021.
21. Pecoits-Filho R, Araujo MR, Lindholm B et al. Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate. Nephrol Dial Transplant 2002; 17: 1480-1486.
22. Quintas A, Vaz DV, Cardoso ID et al. Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants. J Biol Chem 2001; 276: 27207-27213.
23. Raaijmakers R, Pluk W, Schröder C et al. Proteomic profiling and identification in peritoneal fluid of children treated by peritoneal dialysis. Nephrol Dial Transplant 2008; 23: 2402-2405. (Pubitemid 351957640)
24. Rawlings ND, Tolle DP, Barrett AJ. Evolutionary families of peptidase inhibitors. Biochem J 2004; 378: 705-716. (Pubitemid 38406845)
25. Reixach N, Deechongkit S, Jiang X et al. Tissue damage in the amyloidoses: transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture. Proc Natl Acad Sci USA 2004; 101: 2817-2822. (Pubitemid 38327694)
26. Richardson DL, Pepper DS, Kay AB. Chemotaxis for human monocytes by fibrinogen-derived peptides. Br J Haematol 1976; 32: 507-513.
27. Rippe B, Stelin G, Haraldsson B. Computer simulations of peritoneal fluid transport in CAPD. Kidney Int 1991; 40: 315-325.
28. Schäffler A, Neumeier M, Herfarth H et al. Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim Biophys Acta 2005; 1732: 96-102. (Pubitemid 43267310)
29. Shevchenko A, Wilm M, Vorm O et al. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 1996; 68: 850-858.
30. Sritippayawan S, Chiangjong W, Semangoen T et al. Proteomic analysis of peritoneal dialysate fluid in patients with different types of peritoneal membranes. J Proteome Res 2007; 6: 4356-4362. (Pubitemid 350158511)
31. Wang HY, Tian YF, Chien CC et al. Differential proteomic characterization between normal peritoneal fluid and diabetic peritoneal dialysate. Nephrol Dial Transplant 2010; 25: 1955-1963.
32. www.ebi.ac.uk/GOA/] GOAGDh.
33. Zweers MM, de Waart DR, Smit W et al. Growth factors VEGF and TGF-beta1 in peritoneal dialysis. J Lab Clin Med 1999; 134: 124-132 (Pubitemid 29375441)